Table 2 Legal framework and public funding for fertility preservation for cancer patients
Legal framework | Public healthcare system | |
|---|---|---|
France
| Legal recommendation to offer Bioethics Law 2004 august 6 - Article L.2141–11 “For the subsequent realization of an Assisted Reproductive Technology, any person can benefit from the collection and preservation of his gametes or germinal tissue, when a medical treatment is likely to alter fertility or when fertility is likely to be prematurely altered.” | Coverage by healthcare system for treatments inducing a loss of fertility Social Security Code - Article D322–1 “The list of conditions involving prolonged treatment and particularly expensive treatment that may give entitlement to withdrawal of the participation of the insured persons (...): malignant tumor, malignant disease of the lymphatic or hematopoietic tissue.” |
Canada
| No legal recommendation to offer | No funding by healthcare system, except in the province of Quebec, where theLaw 20 Division XII.2says: “If rendered to a fertile insured person before any oncological chemotherapy treatment or radiotherapy treatment involving a serious risk of (…) permanent infertility, (…) the fertility preservation services listed below must be considered insured services (…): (a) the services required for ovarian stimulation or ovulation induction; (b) the services required to retrieve eggs or ovarian tissue; (…)” |
Morocco
| No legal recommendation to offer | No funding by healthcare system |
